Literature DB >> 23707533

Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NF-κB-mediated feeding behavior in phenylpropanolamine-treated rats.

Yih-Shou Hsieh1, Pei-Ni Chen, Ching-Han Yu, Jiuan-Miaw Liao, Dong-Yih Kuo.   

Abstract

Neuropeptide Y (NPY) and nuclear factor-kappa B (NF-κB) are involved in regulating anorexia elicited by phenylpropanolamine (PPA), a sympathomimetic drug. This study explored whether NPY Y1 receptor (Y1R) is involved in this process, and a potential role for the proopiomelanocortin system was identified. Rats were given PPA once a day for 4days. Changes in the hypothalamic expression of the NPY, Y1R, NF-κB, and melanocortin receptor 4 (MC4R) levels were assessed and compared. The results indicated that food intake and NPY expression decreased, with the largest reductions observed on Day 2 (approximately 50% and 45%, respectively), whereas NF-κB, MC4R, and Y1R increased, achieving maximums on Day 2 (160%, 200%, and 280%, respectively). To determine the role of Y1R, rats were pretreated with Y1R antisense or a Y1R antagonist via intracerebroventricular injection 1h before the daily PPA dose. Y1R knockdown and inhibition reduced PPA anorexia and partially restored the normal expression of NPY, MC4R, and NF-κB. The data suggest that hypothalamic Y1R participates in the appetite-suppression from PPA by regulating MC4R and NF-κB. The results of this study increase our understanding of the molecular mechanisms in PPA-induced anorexia.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707533     DOI: 10.1016/j.yhbeh.2013.05.005

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  5 in total

1.  Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction.

Authors:  Yu-Yan Qin; Xiao-Ru Huang; Jian Zhang; Wenjing Wu; Junzhe Chen; Song Wan; Xi-Yong Yu; Hui-Yao Lan
Journal:  Mol Ther       Date:  2021-10-08       Impact factor: 11.454

2.  Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats.

Authors:  Ching-Han Yu; Yih-Shou Hsieh; Pei-Ni Chen; Jeng-Rung Chen; Dong-Yih Kuo
Journal:  Br J Pharmacol       Date:  2018-01-11       Impact factor: 8.739

3.  Involvement of hypothalamic PI3K-STAT3 signalling in regulating appetite suppression mediated by amphetamine.

Authors:  Shu-Chen Chu; Pei-Ni Chen; Yih-Shou Hsieh; Ching-Han Yu; Meng-Hsuan Lin; Yan-Han Lin; Dong-Yih Kuo
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

4.  Hypothalamic TLR2 triggers sickness behavior via a microglia-neuronal axis.

Authors:  Sungho Jin; Jae Geun Kim; Jeong Woo Park; Marco Koch; Tamas L Horvath; Byung Ju Lee
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

5.  The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.

Authors:  Yih-Shou Hsieh; Pei-Ni Chen; Ching-Han Yu; Jiuan-Miaw Liao; Dong-Yih Kuo
Journal:  Mol Brain       Date:  2013-11-13       Impact factor: 4.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.